Picture of Lumiera Health logo

NHP Lumiera Health Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-50.73%
3m-53.22%
6m-76.62%
1yr-68.53%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-336.98%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Nov 202330th Nov 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Lumiera Health EPS forecast chart

Profile Summary

Lumiera Health Inc. is a Canada-based natural health products company. The principal business of the Company is that of selling natural and homeopathic products. The Company specializes in the development and commercialization of evidence-based botanical products for the healthcare industry. The Company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. It is also developing and commercializing a portfolio of innovative solutions in high growth categories such as sleep-aids and pain management. Its product's portfolio categories such as topical pain relief, sleep, skin care, women's health, & infections. The Company’s products and brands include Holizen, Awaye pain relief cream and Bazzzics. The Holizen portfolio has over 20 products that cover a range of therapeutic needs, including cardiovascular health; stress relief; bones, joints & muscle mobility; energy and immunity.

Directors

Last Annual
November 30th, 2022
Last Interim
August 31st, 2023
Incorporated
February 6th, 2013
Public Since
November 14th, 2013
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
ca flag iconTSX Venture Exchange
Shares in Issue
169,965,217

NHP Share Price Performance

Upcoming Events for NHP

Similar to NHP

Picture of Aequus Pharmaceuticals logo

Aequus Pharmaceuticals

ca flag iconTSX Venture Exchange

Picture of Avricore Health logo

Avricore Health

ca flag iconTSX Venture Exchange

Picture of Biosyent logo

Biosyent

ca flag iconTSX Venture Exchange

Picture of Cytophage Technologies logo

Cytophage Technologies

ca flag iconTSX Venture Exchange

Picture of Decibel Cannabis logo

Decibel Cannabis

ca flag iconTSX Venture Exchange

FAQ